Physician profile
Nisha Satish
NPI 1063671865
$1,264.03
in general payments reported to CMS, 2019-2025
19 companies · $60.47 in 2025
The $60.47 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $80.64 · 2021: $267 · 2022: $74.63 · 2023: $68.70 · 2024: $99.32 · 2025: $60.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.15 | 2021-2024 | Vraylar, Qulipta |
| Sunovion Pharmaceuticals INC. | $191.83 | 2019-2020 | |
| Novo Nordisk INC | $147.53 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $133.63 | 2019-2024 | Abilify Maintena, Abilify Asimtufii |
| Eisai INC. | $85.01 | 2019-2021 | |
| Alkermes, INC. | $70.39 | 2019-2021 | |
| Brainsway USA INC | $53.40 | 2019 | |
| Allergan, INC. | $41.49 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $39.35 | 2019 | |
| Medtronic, INC. | $37.27 | 2025 | Corevalve Evolut R |
| Teva Pharmaceuticals USA, INC. | $33.77 | 2024 | Austedo Xr |
| Lundbeck LLC | $31.42 | 2022-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $27.20 | 2019 | |
| Merck Sharp & Dohme LLC | $24.47 | 2019 | |
| Biotronik INC. | $23.20 | 2025 | Amvia Edge |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.12 | 2023 | Proclaim |
| Kyowa Kirin, INC. | $16.52 | 2023 | Crysvita |
| Orexo US, INC. | $13.18 | 2019 | |
| Upsher-Smith Laboratories LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Satish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.